Surface electrocardiogram screening for subcutaneous implantable cardioverter-defibrillators: the comparison between Brugada syndrome and non-Brugada syndrome

被引：0
|
作者：
Kawabata, M. [1 ]
Goya, M. [1 ]
Sasaki, T. [1 ]
Maeda, S. [1 ]
Shirai, Y. [1 ]
Nishimura, T. [1 ]
Yoshitake, T. [1 ]
Shiohira, S. [1 ]
Hirao, K. [1 ]
机构：
[1] Tokyo Med & Dent Univ, Heart Rhythm Ctr, Tokyo, Japan
来源：
EUROPEAN HEART JOURNAL | 2016年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P3507
引用
收藏
页码：693 / 693
页数：1
相关论文
共 50 条
  • [21] Incidence of atrial tachyarrhythmias in patients with early repolarization syndrome and Brugada syndrome: analysis of patients with implantable cardioverter defibrillators
    Hwang, K. W.
    Nam, G. B.
    Lee, W. S.
    Kwon, C. H.
    Kim, Y. R.
    Kim, Y. G.
    Choi, K. J.
    Kim, Y. H.
    EUROPEAN HEART JOURNAL, 2013, 34 : 267 - 267
  • [22] Optimizing the clinical use of implantable defibrillators in patients with Brugada syndrome
    Sarkozy, Andrea
    Brugada, Pedro
    Mont, Lluis
    Brugada, Josep
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2007, 9 (0I) : I74 - I80
  • [23] Impact of electrocardiogram screening during drug challenge test for the prediction of T-wave oversensing by a subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome
    Tsukasa Kamakura
    Mitsuru Wada
    Kohei Ishibashi
    Yuko Y. Inoue
    Koji Miyamoto
    Hideo Okamura
    Satoshi Nagase
    Takashi Noda
    Takeshi Aiba
    Satoshi Yasuda
    Kengo Kusano
    Heart and Vessels, 2017, 32 : 1277 - 1283
  • [24] Impact of electrocardiogram screening during drug challenge test for the prediction of T-wave oversensing by a subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome
    Kamakura, Tsukasa
    Wada, Mitsuru
    Ishibashi, Kohei
    Inoue, Yuko Y.
    Miyamoto, Koji
    Okamura, Hideo
    Nagase, Satoshi
    Noda, Takashi
    Aiba, Takeshi
    Yasuda, Satoshi
    Kusano, Kengo
    HEART AND VESSELS, 2017, 32 (10) : 1277 - 1283
  • [25] Remote implantable cardioverter defibrillator monitoring in a Brugada syndrome population
    Sacher, Frederic
    Probst, Vincent
    Bessouet, Maider
    Wright, Matthew
    Maluski, Alexandre
    Abbey, Selim
    Bordachar, Pierre
    Deplagne, Antoine
    Ploux, Sylvain
    Lande, Gilles
    Jais, Pierre
    Hocini, Meleze
    Haissaguerre, Michel
    Le Marec, Herve
    Clementy, Jacques
    EUROPACE, 2009, 11 (04): : 489 - 494
  • [26] Propofol for implantable cardioverter defibrillator implantation in patients with Brugada syndrome
    Kwon, Hye-Mee
    Kim, Sung-Hoon
    Park, Se-Ung
    Rhim, Jin-Ho
    Park, Hee-Sun
    Kim, Wook-Jong
    Nam, Gi-Byoung
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2018, 41 (06): : 656 - 660
  • [27] Brugada syndrome: Eligibility for subcutaneous implantable cardioverter-defibrillator after exercise stress test
    von Hafe, Pedro
    Faria, Bebiana
    Dias, Geraldo
    Cardoso, Filipa
    Alves, Maria Jose
    Alves, Assuncao
    Rodrigues, Bernardete
    Ribeiro, Silvia
    Sanfins, Victor
    Lourenco, Antonio
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2021, 40 (01) : 33 - 38
  • [28] The Brugada syndrome: Is an implantable cardioverter defibrillator the only therapeutic option?
    Belhassen, B
    Viskin, S
    Antzelevitch, C
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2002, 25 (11): : 1634 - 1640
  • [29] Exercise stress test reveals ineligibility for subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome
    Tachibana, Motomi
    Nishii, Nobuhiro
    Morita, Hiroshi
    Nakagawa, Koji
    Watanabe, Atsuyuki
    Nakamura, Kazufumi
    Ito, Hiroshi
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2017, 28 (12) : 1454 - 1459
  • [30] Eligibility for subcutaneous cardioverter-defibrillator in patients with Brugada syndrome
    Conte, G.
    Caputo, M. L.
    Chiodini, A.
    Ruggiero, D.
    Regoli, F.
    De Asmundis, C.
    Moccetti, T.
    Brugada, P.
    Auricchio, A.
    EUROPEAN HEART JOURNAL, 2016, 37 : 104 - 104
12345